Form Type:  8-K
Filing Date:  6/10/2013 
CIK:  0001131324 
Address:  301 PENOBSCOT DRIVE 
City, State, Zip:  REDWOOD CITY, California 94063 
Telephone:  650-556-9300 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
-0.30 (-1.12%)  
Trade Time: 
Apr 24  
Market Cap: 
Description of Business
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this report, the words "expects," "anticipates," "intends," "estimates," "plans," "believes," and similar expressions are intended to identify forward-looking statements. These are statements that relate to future periods and include statements about our expectation that, for the foreseeable future, a significant amount of our revenues will be derived from Oncotype DX for invasive breast cancer; the factors that may impact our financial results; our ability to achieve sustained profitability; our business strategy and our ability to achieve our strategic goals; our expectations regarding product revenues and the sources of those revenues; the amount of future revenues that we may derive from Medicare patients or categories of patients; our belief that we may become more dependent on Medicare reimbursement in the future; our plans to pu
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
      Item 5.07 Submission of Matters to a Vote of Security ...